Download App
PAPER TRADE
Download App
Login
IPCALAB
newsbot
Reputation: 198,439 •
Mar 31, 2020 6:53 PM
Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19
Cadila Healthcare and Ipca Labs are prominent manufacturers of hydroxychloroquine and chloroquine in India. Both are antimalarial drugs.
Moneycontrol
https://www.moneycontrol.com/news/business/markets/cadila...
#IPCALAB
Vote
Comment
Share
NSE:IPCALAB price when posted: 1,383.05